Prognostic factors in patients with carcinoma of the vulva– our own experience and literature review

Aim of the study: The objective was the analysis of prognostic factors and treatment outcomes of 104 patients with vulvar cancer, treated between 1990 and 2003 in the Center of Oncology, Maria Sklodowska-Curie Memorial Institute, Cracow, Poland. Material and Methods: The median age of patients was 67. Advanced disease (TNM III and IVA) was found in 54 (51.9%) patients and grade 2 and 2 in 50 (48.1%). Inguinal lymph nodes were clinically uni- or bilaterally involved in 40.4% of patients. Fifty-seven (54.8%) patients underwent radical vulvectomy with bilateral inguinal lymphadenectomy and 47 (45.2%) radical vulvectomy only. Cancer differentiation was well in 38 (36.2%) of patients, moderate in 38 (36.2%) and poor in 28 (36.6%). Adjuvant radiotherapy was applied in 30 (28.8%) cases. Results: Five-year overall survival rate was observed in 44.4% of patients. Depending on TNM grade, 5-year OS rates were 61.4% for grade 1, 54.9% for grade 2, 40.1% for grade 3 and 13.3% for IVA. In patients aged < 70, 5-year OS rate was 54.7% compared to 30.5% for those >= 70. Among patients with G1 cancer differentiation 64.4% survived five years, with G2 39.1% and with G3 24.9%, respectively. Conclusion: Univariate analysis revealed a statistically significant, unfavorable impact of age >= 70, with G3 cancer differentiation. clinically confirmed inguinal lymph node involvement and TNM classification stage on 5-year overall survival. Cox multivariate analysis demonstrated that independent prognostic factors for 5-year survival were the age of the patient, clinical status of inguinal lymph nodes and TNM classification grade.

Carcinoma of the vulva; Prognostic factors

[1] Hacker N.F.: “Vulvar cancer”. Berek J.S., Hacker N.F. Practical Gynecologic Oncology. Philadelphia, Lippincott Williams and Wilkins 2005, 542.

[2] Moore D.H., Koh W.J., McGuire W.P., Wilkinson E.J.: “Vulva”. In: Hoskins W.J., Perez C.A., Young R.C., Barakat R.R., Markman M., Randall M.E. (eds.): “Principles and Practice of Gynecologic Oncology”, 4th edition, Philadelphia, Lippincott Williams and Wilkins, 2005, 665.

[3] Greene F.L., Page D.L., Fleming I., Fritz A., Balch C., Haller D. et al.: “AJCC Cancer Staging Manual”. New York, Springer-Verlay, 2002.

[4] Cox D.R.: “Regression models and life-tables (with discussion)”. J. R. Stat. Soc. B., 1972, 34, 187.

[5] Binder S.W., Huang I., Fu Y.S., Hacker N.F., Berek J.S.: “Risk factors for the development of lymph node metastasis in vulvar squamous cell carcinoma”. Gynecol. Oncol., 1990, 37, 9.

[6] Heaps J.M., Fu Y.S., Montz F.J., Hacker N.F., Berek J.S.: “Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva”. Gynecol. Oncol., 1990, 38, 309.

[7] Homesley H.D., Bundy B.N., Sedlis A.: “Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (Gynecologic Oncology Group study)”. Gynecol. Oncol., 1993, 4, 279.

[8] Hopkins M.P., Reid G.C., Vettrano I., Morley G.W.: “Squamous cell carcinoma of the vulva: prognostic factors influencing survival”. Gynecol. Oncol., 1991, 43, 113.

[9] Magrina J.F., Gonzalez-Bosquet J., Weaver A.L., Gaffey T.A., Webb M.J., Podratz K.C. et al.: “Primary squamous cell cancer of the vulva: radical versus modified radical vulvar surgery”. Gynecol. Oncol., 1998, 71, 116.

[10] Rosen C., Malmstrom H.: “Invasive cancer of the vulva”. Gynecol. Oncol., 1997, 65, 213.

[11] Rouzier R., Haddad B., Plantier F., Dubois P., Pelisse M., Paniel B.J.: “Local relapse in patients treated for squamous cell vulvar carcinoma: incidence and prognostic value”. Obstet. Gynecol., 2002, 100, 1159.

[12] Rutledge F.N., Mitchell M.F., Munsell M.F., Atkinson E.N., Bass S., McGuffee V. et al.: “Prognostic indicators for invasive carcinoma of the vulva”. Gynecol. Oncol., 1991, 42, 239.

[13] Cavanagh D., Fiorica J.V., Hoffman M.S., Roberts W.S., Bryson S.C., LaPolla J.P. et al.: “Invasive carcinoma of the vulva: changing trends in surgical management”. Am. J. Obstet. Gynecol., 1990, 163, 1007.

[14] Homesley H.D., Bundy B.N., Sedlis A.: “Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study)”. Am. J. Obstet. Gynecol., 1991, 164, 997.

[15] Origoni M., Sideri M., Garsia S., Carinelli S.G., Ferrari A.G.: “Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva Stage III and IVA FIGO”. Gynecol. Oncol., 1992, 45, 313.

[16] Rodolakis A., Diakomanolis E., Voulgaris Z., Akrivos T., Vlachos G., Michalas S. et al.: “Squamous vulvar cancer: a clinically based individualization of treatment”. Gynecol. Oncol., 2000, 78, 346.

[17] Simonsen E.: “Treatment of recurrent squamous cell carcinoma of the vulva”. Acta Radiol. Oncol., 1984, 23, 345.

[18] Malfetano J.H., Piver M.S., Tsukada Y.: “Stage III and IV squamous cell carcinoma of the vulva”. Gynecol. Oncol., 1986, 23, 192.

[19] Holschneider C.H., Berek J.S.: “Vulva”. In: Heskell C.M. (ed.) Cancer Treatment, 5th edition, Philadelphia, W.B. Saunders, 2000, 966.

[20] Farias-Eisner R., Cirisano F.D., Grouse D., Leuchter R.S., Karlan B.Y., Lagasse L.D. et al.: “Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for Stage I and II (T1-2 N0-1 M0) disease”. Gynecol. Oncol., 1994, 53, 55.

[21] Dusenbery K.E., Carlson J.W., LaPorte R.M., Unger J.A., Goswitz J.J., Roback D.M. et al.: “Radical vulvectomy with postoperative irradiation for vulvar cancer. Therapeutic implications of a central block”. Int. J. Radiat. Oncol. Biol. Phys., 1994, 29, 989.

[22] Russell A.H.: “Cancer of the vulva”. In: Leibel S.A., Philips T.L.(eds.), Textbook of Radiation Oncology (2nd edn.), Philadelphia, W.B. Saunders, 2004, 117.

[23] Boyce J., Fruchter R.G., Kasambilides E., Nicastri A.D., Sedlis A., Remy J.C. et al.: “Prognostic factors in carcinoma of the vulva”. Gynecol. Oncol., 1985, 20, 364.

[24] Hacker N.F., Berek J.S., Lagasse L.D.: “Management of regional lymph-nodes and their prognostic influence in vulvar cancer”. Obstet. Gynecol., 1983, 61, 408.

[25] Paladini D., Cross P., Lopes A.: “Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva”. Cancer, 1994, 74, 2491.

[26] Malmstrom H., Janson H., Simonsen E., Sténson S., Stendahl U.: “Prognostic factors in invasive squamous cell carcinoma of the vulva treated with surgery and irradiation”. Acta Oncol., 1990, 29, 915.

[27] Curry S.L., Wharton J.T., Rutledge F.: “Positive lymph nodes in vulvar squamous carcinoma”. Gynecol. Oncol., 1980, 9, 63.